Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Conditions

• Metabolic Associated Fatty Liver Disease
• Metabolic Associated-dysfunction Steatohepatitis (MASH)
• Obesity

Interventions

• DRUG: semaglutide
• OTHER: Diet

Sponsor

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval